Research conducted by a partnership between the Coriell Personalized Medicine Collaborative (CPMC) study and the Ohio State University Wexner Medical Center examines the significance of genomic counseling, as it relates to the patient-physician exchange.
read moreDr. Dorit Berlin, Coriell's Director of Biobanking, has been selected by a business publication as one of the region's top researchers in healthcare.
read moreSenator Booker toured the Coriell laboratories while accompanied by United States Representative Donald Norcross (D, first congressional district) and Camden City Mayor Dana Redd.
read moreAs part of a series profiling transformational companies and emergent industry trends, the Philadelphia Business Journal has recognized Coriell Institute and its for-profit spinoff venture, Coriell Life Sciences (CLS), as standout organizations.
read moreAlready possessing the largest publicly available collection of human iPS cell lines, Coriell has crossed the 100 iPS cell line threshold and continues to stimulate important biomedical research at the international level.
read moreIn mid-January, Coriell Institute welcomed one of the nation's most influential healthcare reform experts, Dr. Jeffrey Brenner.
read moreAt a summit of the state's most innovative organizations and thought leaders, the New Jersey Technology Council (NJTC) heralded Coriell Life Sciences (CLS) as 2014's top startup company.
read moreScientists from elite institutions all around the country are using biospecimens from the world-renowned Coriell Institute Biobank to conduct meaningful Ebola virus disease research.
read moreA reporter with the Wall Street Journal investigating the relationship between the Ebola virus disease and a rare genetic disorder referenced Coriell's world-renowned biobank.
read moreResearch conducted by Coriell Institute and The Ohio State University (OSU) was featured by a major medical news outlet and also took center stage at a top genetics conference earlier this month.
read more